Utility of 24(S)-hydroxycholesterol as a proximal biomarker to monitor long-term intrathecal adrabetadex therapy in individuals with Niemann-Pick disease, type C1.
- DOI
- 10.1016/j.ymgme.2025.109254
- Published
- 2025 Dec
- Container
- Molecular genetics and metabolism
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ymgme.2025.109254,
title = {Utility of 24(S)-hydroxycholesterol as a proximal biomarker to monitor long-term intrathecal adrabetadex therapy in individuals with Niemann-Pick disease, type C1.},
author = {Porter FD and Alexander DM and Albert OK and Robbins KP and Labor DA and Borruso AJ and Farhat NY and Jiang X and Berry-Kravis E},
year = {2025},
journal = {Molecular genetics and metabolism},
doi = {10.1016/j.ymgme.2025.109254},
url = {https://doi.org/10.1016/j.ymgme.2025.109254}
}RIS
TY - JOUR TI - Utility of 24(S)-hydroxycholesterol as a proximal biomarker to monitor long-term intrathecal adrabetadex therapy in individuals with Niemann-Pick disease, type C1. AU - Porter FD AU - Alexander DM AU - Albert OK AU - Robbins KP AU - Labor DA AU - Borruso AJ AU - Farhat NY AU - Jiang X AU - Berry-Kravis E PY - 2025 JO - Molecular genetics and metabolism DO - 10.1016/j.ymgme.2025.109254 UR - https://doi.org/10.1016/j.ymgme.2025.109254 ER -
APA
FD, P., DM, A., OK, A., KP, R., DA, L., AJ, B., NY, F., X, J., & E, B. (2025). Utility of 24(S)-hydroxycholesterol as a proximal biomarker to monitor long-term intrathecal adrabetadex therapy in individuals with Niemann-Pick disease, type C1.. Molecular genetics and metabolism. https://doi.org/10.1016/j.ymgme.2025.109254
Source records
- pubmed · retrieved 2026-09-26T22:12:20.806Z